Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) is a brand-name tablet prescribed for HIV-1. As with other drugs, Biktarvy can cause side effects, such as ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...

Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

The new study looked at 198 kidney transplants performed across the U.S. Researchers found similar results whether the ...

Keep reading to find out the key distinctions between HIV and AIDS, including symptoms, progression, treatment options, and overall impact on health. Are HIV and AIDS the Same Thing? HIV and AIDS ...

Needle sharing is the second biggest risk for HIV. About 1 in 10 new HIV infections happen in people who inject drugs. HIV tests are now easy to get and affordable. But if money is tight ...

We also provide primary care and referrals for HIV treatment to optimize the health and wellness of people living with HIV/AIDS. You can obtain information about HIV testing from your medical provider ...

Gilead Sciences Inc. (GILD) and Merck & Co Inc.(MRK) announced new results from a Phase 2 clinical study evaluating the ...

supporting its value in HIV ARV medication adherence studies (Nieuwkerk and Oort 2005; Simoni et al. 2006). An obstacle to progress in the HIV ARV medication adherence field has been the absence ...

Early diagnosis is vital for HIV. The sooner you receive a blood test and diagnosis, the sooner you can start treatment to bring and keep HIV at undetectable levels. Staying in close contact with ...